(USD) | Dec 2022 | Q/Q |
---|---|---|
Revenue | 522.3MM | -3% |
Gross Profit | 374.5MM | +3% |
Cost Of Revenue | 147.8MM | -15% |
Operating Income | 27.5MM | -235% |
Operating Expenses | 347.1MM | -10% |
Net Income | 57.2MM | -325% |
G&A | 127.7MM | -7% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
PROVO, Utah, May 14, 2024--Nu Skin, a global leader in beauty and wellness, today released its 2023 Social Impact and Sustainability Report. The report outlines progress on the company’s environmental and social priorities, including its sustainability commitments and global giving efforts.
Every investor on earth makes bad calls sometimes. But you have a problem if you face massive losses more than once in...
Comprehensive Analysis of Nu Skin's First Quarter Financial Performance
Nu Skin's (NUS) first-quarter 2024 results reflect challenges related to volatile currency movements, while cost-management efforts work well.
Nu Skin Enterprises, Inc. (NYSE:NUS) Q1 2024 Earnings Call Transcript May 8, 2024 Nu Skin Enterprises, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day. Thank you for standing by. Welcome to the Q1 2024 Nu Skin Enterprise […]
Q1 2024 NU Skin Enterprises Inc Earnings Call
Despite foreign exchange headwinds, Nu Skin navigates through economic pressures with strategic innovations and robust segment growth.
Nu Skin (NUS) delivered earnings and revenue surprises of 80% and 3.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Personal care company Nu Skin (NYSE:NUS) missed analysts' expectations in Q1 CY2024, with revenue down 13.3% year on year to $417.3 million. Next quarter's revenue guidance of $437.5 million also underwhelmed, coming in 3.7% below analysts' estimates. It made a non-GAAP profit of $0.09 per share, down from its profit of $0.37 per share in the same quarter last year.
PROVO, Utah, May 08, 2024--Nu Skin Enterprises Inc. (NYSE: NUS) today announced first quarter results in line with guidance.